A potential probiotic isolated from the rumen of grazing lamb may protect against damage of colon cells and reduce markers of inflammation, says a new study.
A new study confirming that the diet of inflammatory bowel disease (IBD) patients often lacks vitamin D and vitamin K, concludes: “While vitamin D supplementation is the rule, vitamin K shortages need proactive nutritional intervention.”
Biotin deficiencies lead to dysbiosis of the gut and a reduction in mucus-resident microbes, leading to characteristics of Inflammatory Bowel Disease (IBD), according to a new study in mice.
A combination of bacteriophages (phages) may precisely target and suppress gut bacteria associated with inflammatory bowel diseases (IBD), says a new study from Israel that shows the potential of this emerging class of microbiome modulators.
Nestlé Health Science and Enterome are to co-develop and commercialise a series of microbiome-based immunotherapies for food allergies and inflammatory bowel disease (IBD).
Microbiome firm BiomX is to continue collaborating with pharma giants Boehringer Ingelheim in a partnership that looks to identify biomarkers for inflammatory bowel disease (IBD).
Researchers have identified transcriptional interplay between microbial and nutritional responses to a high-fat meal (HFM) in the intestinal epithelial cells (IEC) of mice, which suggest gut microbes influence postprandial gene action.
Artificial sweeteners may interfere with communication between bacterial species that make up the gut microbiome, say researchers, who think this could lead to digestive conditions and discomfort.
Microalgae cultivation start-up Yemoja, Ltd. is joining the MIGAL Galilee Research institute to spearhead an extensive, four-year research initiative to identify algae-sourced compounds with the potential to help manage inflammation and Inflammatory Bowel...
‘Designer’ biotherapeutics rationally designed to address the dysbiotic microbiome seen in Crohn’s disease and ulcerative colitis may be the ‘breakthrough’ researchers are looking for in tackling these conditions.
A synbiotic combination of green banana resistant starch and probiotic Bacillus coagulans MTCC5856 (LactoSpore by Sabinsa) may reduce gut inflammation in a mouse model of inflammatory bowel diseases (IBD), says a new study from Australia.
Most patients with IBD, particularly males, habitually consume inadequate amounts of dietary fibre which may have negative effects on the gut microbiome and contribute to dysbiosis, a cross‐sectional study has concluded.
Flavonoids from a specifically designed corn line may act an anti-inflammatory agent against Inflammatory Bowel Disease (IBD), according to a new study in mice.
We may be able to predict disease relapse in patients with chronic inflammatory bowel diseases based on their microbiome markers, according researchers from APC Microbiome Ireland.
Patients with Crohn’s disease (CD) and ulcerative colitis (UC) could benefit from following a Mediterranean diet, after a study finds an impact on nutritional state and disease activity.
Supplementation with polyphenols from mango may reduce markers of inflammation and improve levels of beneficial bacteria in the gut of people with IBD, suggests a small study funded by the National Mango Board.
A pilot trial tested the effect of skin UVB exposure on the human gut microbiome and found changes in the human gut microbiota in response to UVB light
The number of people suffering from inflammatory bowel diseases (IBD) is three times higher than previous estimates, with sufferers also at a higher risk of developing colorectal cancer (CRC), according to new research.
Many commonly used drugs significantly impair our microbiome health and increase our risk of intestinal infections, obesity and other serious conditions, according to a new study.
